Your location doesn't match the address (URL), do you want to change it?
Please note that by changing your country/language, you will be starting a new session on a different version of our site and redirected to the homepage.
Each country/region may have its own set of regulatory requirements and medical practices. The information found on each country version of our website is specific to and applicable for only that country/region.
This includes (but is not limited to) all product details/availability, documentation, pricing, and promotions.
Novocastra p16 antibody demonstrated an agreement of 98% with the Roche p16 antibody The study compared the percentage agreement rates of Novocastra’s p16 (6H12) IVD solution with Roche CINtec® Histology p16 assay on 170 oropharyngeal cancer cases.
NEW STUDY SHOWS BOND-III UP TO 40% FASTER THAN BENCHMARK ULTRA In a recent study, the Leica Biosystems BOND-III was found to complete cases up to 100 minutes faster than the Roche Tissue Diagnostics BenchMark ULTRA. The study examines the panel turnaround...